Welcome to LookChem.com Sign In|Join Free
  • or
Piperazine, 1-[(1R)-1-(4-bromophenyl)ethyl]-2,6-dimethyl-4-(4-piperidinyl)-, (2R,6R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

821005-16-7

Post Buying Request

821005-16-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

821005-16-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 821005-16-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,1,0,0 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 821005-16:
(8*8)+(7*2)+(6*1)+(5*0)+(4*0)+(3*5)+(2*1)+(1*6)=107
107 % 10 = 7
So 821005-16-7 is a valid CAS Registry Number.

821005-16-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-{4-[1(R)-(4-bromophenyl)-ethyl]-3(R),5(R)-dimethylpiperazin-1-yl}-piperidine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:821005-16-7 SDS

821005-16-7Upstream product

821005-16-7Downstream Products

821005-16-7Relevant academic research and scientific papers

MCH antagonists for the treatment of obesity

-

Page/Page column 12, (2010/02/10)

The present invention discloses methods of using antagonists for melanin-concentrating hormone (MCH), to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes, as well as novel compounds which are antagonists for melanin-concentrating hormone (MCH). In other aspects, the invention is directed to pharmaceutical compositions comprising such MCH antagonists as well as methods for preparing such compounds. Compounds of the invention generally have the structure: where the substituents are as defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 821005-16-7